Following criticism from drugmakers, Germany has scrapped its plan to install a program that would have reduced the prices of branded pharmaceuticals through a variable structure, according to a report from Reuters. More: Germany backs off plan to install variable
read moreIQVIA Digital has developed technology to help pharma marketers identify nurse practitioners and physician associates who write prescriptions. More: IQVIA taps AI to put overlooked prescribers on marketers’ maps Source: fierce
read moreThe FDA approval clears Welireg’s use with Keytruda in earlier-stage kidney cancer, following its 2023 solo nod for advanced disease. More: Merck's Welireg-Keytruda pairing sticks the landing in adjuvant kidney cancer treatment with new FDA nod Source: fierce
read moreSanofi has gained an FDA expansion for its Type 1 diabetes treatment Tzield. The decision came nearly two months after an original target date under former FDA chief Marty Makary’s controversial Commissioner’s National Priority Voucher (CNPV) program. More: Sanofi, once
read moreAs the United Kingdom juggles industry concerns about the region’s waning appeal and competitiveness, Eisai is getting a lift from a production-tinged fund that the British government first unveiled in 2024. More: Eisai snares government manufacturing grant as it brings
read more© 1994 - 2026 B.M. Pharmaceuticals